$782 Million is the total value of First Light Asset Management, LLC's 69 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $67,746,000 | +9.5% | 4,081,055 | +9.7% | 8.66% | -7.4% |
| KRMD | Buy | REPRO-MED SYSTEMS INC | $47,134,000 | +66.2% | 7,218,014 | +0.5% | 6.02% | +40.5% |
| NEO | Buy | NEOGENOMICS INC | $39,106,000 | +55.0% | 1,336,949 | +1.3% | 5.00% | +31.0% |
| ATRC | Buy | ATRICURE INC | $36,174,000 | +31.2% | 1,112,698 | +0.6% | 4.62% | +10.9% |
| HALO | Buy | HALOZYME THERAPEUTICS INC | $30,155,000 | +15.5% | 1,700,782 | +1.1% | 3.85% | -2.3% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $24,094,000 | +17.6% | 1,008,957 | +32.0% | 3.08% | -0.6% |
| TEVA | Buy | TEVA PHARMACEUTICAL IND | $16,230,000 | +143.4% | 1,656,171 | +70.9% | 2.08% | +105.9% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $16,010,000 | +99.1% | 268,574 | +97.0% | 2.05% | +68.3% |
| SIBN | Buy | SI-BONE INC | $14,730,000 | +29.0% | 685,131 | +6.1% | 1.88% | +9.1% |
| VAPO | Buy | VAPOTHERM INC | $13,948,000 | +43.9% | 1,147,010 | +12.0% | 1.78% | +21.6% |
| MYL | Buy | MYLAN N V | $10,709,000 | +187.6% | 532,783 | +183.0% | 1.37% | +143.2% |
| TRHC | Buy | TABULA RASA HEALTHCARE INC | $10,208,000 | -4.9% | 209,689 | +7.3% | 1.30% | -19.5% |
| BLUE | Buy | BLUEBIRD BIO INC | $5,668,000 | +231.3% | 64,587 | +246.5% | 0.72% | +179.5% |
| ELGXQ | Buy | ENDOLOGIX INC | $4,558,000 | -59.6% | 2,885,081 | +1.4% | 0.58% | -65.8% |
| GBT | New | GLOBAL BLOOD THERAPEUTICS INC | $1,113,000 | – | 14,000 | +100.0% | 0.14% | – |
| ANTM | New | ANTHEM INC COM | $240,000 | – | 795 | +100.0% | 0.03% | – |
| A | New | AGILENT TECHNOLOGIES INC | $217,000 | – | 2,548 | +100.0% | 0.03% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $203,000 | – | 692 | +100.0% | 0.03% | – |
| BIO | New | BIO RAD LABS INC | $203,000 | – | 548 | +100.0% | 0.03% | – |
| DYNT | Buy | DYNATRONICS CORP | $105,000 | -13.9% | 126,044 | +3.9% | 0.01% | -27.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.